Abstract
Atherosclerosis (AS) is a common pathological basis for many cardiovascular diseases (CVDs) and result in high mortality and immense health and economic burdens worldwide. Early prevention, diagnosis, and treatment are promising approaches for stemming the development and progression of AS. Lactoferrin (Lf) is an iron-binding glycoprotein belonging to the transferrin family. It is widely found in body fluids such as digestive tract fluids, tears, and milk. Lf possesses anti-inflammatory, antibacterial, immunoregulatory, antioxidant and many other physiological functions. The serum Lf level is reportedly associated with the risk of AS and AS-related CVDs. Lf administration is closely involved in several mechanisms, including cholesterol metabolism, foam cell formation, ICAM-1 expression, homocysteine and leptin levels, anti-inflammatory and antioxidant function. Moreover, Lf has also been applied in the sythesis of magnetic resonance imaging (MRI) contrast agents to detect AS. Lf plays an important role in AS and may therefore be used in its diagnosis and treatment. Thus, this article aims to review the association between Lf and the risk of AS and AS-related CVDs, the mechanisms of Lf administration on AS, and its potential application in AS diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Actor JK, Hwang SA, Kruzel ML (2009) Lactoferrin as a natural immune modulator. Curr Pharm Des 15:1956–1973. https://doi.org/10.2174/138161209788453202
Angeli F, Angeli E, Ambrosio G, Mazzotta G, Reboldi G, Verdecchia P (2010) Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular risk. Obstet Gynecol 115:695–703. https://doi.org/10.1097/AOG.0b013e3181d53df6
Badimón L, Vilahur G, Padró T (2009) Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol 62:1161–1178. https://doi.org/10.1016/s1885-5857(09)73331-6
Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D (2000) Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 68:6519–6525. https://doi.org/10.1128/iai.68.12.6519-6525.2000
Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr (1987) Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A 84:9238–9242. https://doi.org/10.1073/pnas.84.24.9238
Chaudhary R, Roy K, Kanwar RK, Walder K, Kanwar JR (2016) Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents. J Nanobiotechnol 14:6. https://doi.org/10.1186/s12951-016-0157-1
Chiang JYL, Ferrell JM (2018) Bile acid metabolism in liver. Pathobiology Gene Expr 18:71–87. https://doi.org/10.3727/105221618x15156018385515
Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA, Orekhov AN (2018) Potential of anti-inflammatory agents for treatment of atherosclerosis. Exp Mol Pathol 104:114–124. https://doi.org/10.1016/j.yexmp.2018.01.008
Crawford SE, Borensztajn J (1999) Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway. J Lipid Res 40:797–805
Embleton ND, Berrington JE, McGuire W, Stewart CJ, Cummings SP (2013) Lactoferrin: antimicrobial activity and therapeutic potential Semin. Fetal Neonatal Med 18:143–149. https://doi.org/10.1016/j.siny.2013.02.001
Frostegård J (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:117. https://doi.org/10.1186/1741-7015-11-117
Giansanti F, Panella G, Leboffe L, Antonini G (2016) Lactoferrin from milk: nutraceutical and pharmacological properties. Pharma (Basel). https://doi.org/10.3390/ph9040061
Hailman E et al (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269–277. https://doi.org/10.1084/jem.179.1.269
Hayashi S, Yamada H, Fukui M, Ito HO, Sata M (2015) Correlation between arteriosclerosis and periodontal condition assessed by lactoferrin and α1-antitrypsin levels in gingival crevicular fluid. Int Heart J 56:639–643. https://doi.org/10.1536/ihj.15-218
Hekmati Azar Mehrabani Z et al (2015) Effects of folic acid supplementation on serum homocysteine and lipoprotein(a) levels during pregnancy. Bioimpacts 5:177–182. https://doi.org/10.15171/bi.2015.26
Huettinger M, Retzek H, Eder M, Goldenberg H (1988) Characteristics of chylomicron remnant uptake into rat liver. Clin Biochem 21:87–92. https://doi.org/10.1016/s0009-9120(88)80093-6
Kajikawa M, Ohta T, Takase M, Kawase K, Shimamura S, Matsuda I (1994) Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins. Biochim Biophys Acta 1213:82–90. https://doi.org/10.1016/0005-2760(94)90225-9
Kapellas K et al (2014) Associations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians. Int J Cardiol 173:190–196. https://doi.org/10.1016/j.ijcard.2014.02.015
Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL (2017) Oxidative stress in atherosclerosis. Curr Atheroscler Rep 19:42. https://doi.org/10.1007/s11883-017-0678-6
Kim CW, Lee TH, Park KH, Choi SY, Kim J (2012) Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells. FEBS Lett 586:229–234. https://doi.org/10.1016/j.febslet.2011.12.011
Kiyanagi T et al (2011) Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis 215:60–69. https://doi.org/10.1016/j.atherosclerosis.2010.10.019
Latorre D, Puddu P, Valenti P, Gessani S (2010) Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response Toxins. (Basel) 2:54–68. https://doi.org/10.3390/toxins2010054
Levula M et al (2012) Genes involved in systemic and arterial bed dependent atherosclerosis–tampere vascular study. PLoS One 7:e33787. https://doi.org/10.1371/journal.pone.0033787
Li-Hawkins J et al (2002) Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest 110:1191–1200. https://doi.org/10.1172/jci16309
Libby P et al (2019) Atherosclerosis. Nat Rev Dis Primers 5:56. https://doi.org/10.1038/s41572-019-0106-z
Ling CJ, Min QQ, Yang JR, Zhang Z, Yang HH, Xu JY, Qin LQ (2019a) Lactoferrin alleviates the progression of atherosclerosis in ApoE(-/-) mice fed with high-fat/cholesterol diet through cholesterol homeostasis. J Med Food 22:1000–1008. https://doi.org/10.1089/jmf.2018.4389
Ling CJ et al (2019b) Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis. Food Funct 10:7299–7307. https://doi.org/10.1039/c9fo01616c
Lönnerdal B (2009) Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 12:293–297. https://doi.org/10.1097/MCO.0b013e328328d13e
Maroufi NF et al (2016) Taq1B polymorphism of cholesteryl ester transfer protein (CETP) and its effects on the serum lipid levels in metabolic syndrome. Patients Biochem Genet 54:894–902. https://doi.org/10.1007/s10528-016-9766-5
Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M (2017) Homocysteine-lowering interventions for preventing cardiovascular events Cochrane. Database Syst Rev 8:Cd006612. https://doi.org/10.1002/14651858.CD006612.pub5
Morishita S et al (2016) Enteric lactoferrin attenuates the development of high-fat and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis in Microminipigs. Biosci Biotechnol Biochem 80:295–303. https://doi.org/10.1080/09168451.2015.1091713
Nakamura K et al (2017) Lactoferrin interacts with bile acids and increases fecal cholesterol excretion in rats. Biochem Cell Biol 95:142–147. https://doi.org/10.1139/bcb-2016-0052
Nicholls SJ, Uno K, Kataoka Y (2011) Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk. Expert Rev Cardiovasc Ther 9:1383–1390. https://doi.org/10.1586/erc.11.145
Nozari S et al (2018) Decreasing serum homocysteine and hypocholesterolemic effects of Bovine lactoferrin in male rat fed with high-cholesterol diet. J Cardiovasc Thorac Res 10:203–208. https://doi.org/10.15171/jcvtr.2018.35
Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M (1999) Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 116:174–180. https://doi.org/10.1046/j.1365-2249.1999.00864.x
Peluso I, Morabito G, Urban L, Ioannone F, Serafini M (2012) Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr Metab Immune Disord Drug Targets 12:351–360. https://doi.org/10.2174/187153012803832602
Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 90:2744–2748. https://doi.org/10.1073/pnas.90.7.2744
Qi K, Seo T, Al-Haideri M, Worgall TS, Vogel T, Carpentier YA, Deckelbaum RJ (2002) Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry 41:3119–3127. https://doi.org/10.1021/bi015770h
Qin M, Luo Y, Lu S, Sun J, Yang K, Sun G, Sun X (2017) Ginsenoside F1 ameliorates endothelial cell inflammatory injury and prevents atherosclerosis in mice through A20-mediated suppression of NF-kB. Signal Front Pharmacol 8:953. https://doi.org/10.3389/fphar.2017.00953
Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H (2007) Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med 167:174–181. https://doi.org/10.1001/archinte.167.2.174
Rascón-Cruz Q, Espinoza-Sánchez EA, Siqueiros-Cendón TS, Nakamura-Bencomo SI, Arévalo-Gallegos S, Iglesias-Figueroa BF (2021) Lactoferrin: a glycoprotein involved in immunomodulation. Anticancer Antimicro Proc Mol. https://doi.org/10.3390/molecules26010205
Roth GA et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Safaeian L, Javanmard SH, Mollanoori Y, Dana N (2015) Cytoprotective and antioxidant effects of human lactoferrin against H2O2-induced oxidative stress in human umbilical vein endothelial cells. Adv Biomed Res 4:188. https://doi.org/10.4103/2277-9175.164010
Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521–1528. https://doi.org/10.1161/01.atv.14.10.1521
Seinost G et al (2005) Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 149:1050–1054. https://doi.org/10.1016/j.ahj.2004.09.059
Shiralizadeh J et al (2017) The effects of high and low doses of folic acid on oxidation of protein levels during pregnancy: a randomized double-blind clinical trial. Horm Mol Biol Clin Investig. https://doi.org/10.1515/hmbci-2017-0039
Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products. Rev Diabetologia 44:129–146. https://doi.org/10.1007/s001250051591
Sugizaki T et al (2014) The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice. Endocrinology 155:2810–2819. https://doi.org/10.1210/en.2013-2143
Takeuchi T, Shimizu H, Ando K, Harada E (2004) Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents. Br J Nutr 91:533–538. https://doi.org/10.1079/bjn20041090
Ticala M et al (2020) Relationship between vascular cell adhesion molecule-1 (VCAM-1), soluble receptor for advanced glycation end products (sRAGE) and functional hemodynamic parameters of arteriovenous fistula. J Vasc Access. https://doi.org/10.1177/1129729820976264
Trentini A et al (2020) Vaginal lactoferrin administration decreases oxidative stress in the amniotic fluid of pregnant women: an open-label randomized pilot study. Front Med (Lausanne) 7:555. https://doi.org/10.3389/fmed.2020.00555
Uribarri J et al (2015) Dietary advanced glycation end products and their role in health and disease. Adv Nutr 6:461–473. https://doi.org/10.3945/an.115.008433
Vasilyev VB, Sokolov AV, Kostevich VA, Elizarova AY, Gorbunov NP, Panasenko OM (2021) Binding of lactoferrin to the surface of low-density lipoproteins modified by myeloperoxidase prevents intracellular cholesterol accumulation by human blood monocytes. Biochem Cell Biol 99:109–116. https://doi.org/10.1139/bcb-2020-0141
Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V (2010) Lactoferrin is a novel predictor of fatal ischemic heart disease in diabetes mellitus type 2: long-term follow-up of the HUNT 1 study. Atherosclerosis 212:614–620. https://doi.org/10.1016/j.atherosclerosis.2010.06.008
Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P (2007) Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol 118:81–87. https://doi.org/10.1016/j.ijcard.2006.07.005
Videm V, Dahl H, Wålberg LE, Wiseth R (2012) Functional polymorphisms in the LTF gene and risk of coronary artery stenosis. Hum Immunol 73:554–559. https://doi.org/10.1016/j.humimm.2012.02.014
Virani SS et al (2020) Heart Disease and Stroke Statistics-2020 Update: A Report From. Am Heart Assoc Circu 141:e139–e596. https://doi.org/10.1161/cir.0000000000000757
Wang Y, Ding WX, Li T (2018) Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids 1863:726–733. https://doi.org/10.1016/j.bbalip.2018.04.005
Winters B et al (2000) Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol (1985) 89:2382–2390. https://doi.org/10.1152/jappl.2000.89.6.2382
Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315–327. https://doi.org/10.1161/circresaha.118.313591
Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzmán M, Brownlee M (2001) Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase. A J Biol Chem 276:25096–25100. https://doi.org/10.1074/jbc.M007383200
Yeom M, Park J, Lee B, Choi SY, Kim KS, Lee H, Hahm DH (2011) Lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells. Inflamm Res 60:475–482. doi:https://doi.org/10.1007/s00011-010-0294-1
Zhang Y, Lu C, Zhang J (2021a) Lactoferrin and its detection methods. Rev Nutri. https://doi.org/10.3390/nu13082492
Zhang Z et al (2021b) Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics 11:3167–3182. https://doi.org/10.7150/thno.52028
Zhu Y et al (2018) Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. https://doi.org/10.3390/biom8030080
Ziere GJ, van Dijk MC, Bijsterbosch MK, van Berkel TJ (1992) Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem 267:11229–11235
Ziere GJ, Kruijt JK, Bijsterbosch MK, Berkel TJ (1996) Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of the remnant receptor. Z Gastroenterol 34 Suppl 3:118–121
Acknowledgements
This study was financially supported by a grant from the National Natural Science Foundation of China (No. 82103812). This study was also supported by the High-level Innovation and Entrepreneurship Talent Introduction Plan of Jiangsu Province (Grant No. JSSCBS20211579) and Suzhou Gusu Health Talents Project (no. GSWS2021031).
Author information
Authors and Affiliations
Contributions
ZZ and LQQ designed the review. MLL performed literature search. CLC, ZZ and LQQ drafted the manuscript and, critically revised and approved the final version of the manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Informed consent
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, C., Lu, M., Zhang, Z. et al. The role of lactoferrin in atherosclerosis. Biometals 36, 509–519 (2023). https://doi.org/10.1007/s10534-022-00441-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-022-00441-1